Publication | Open Access

Lower Gastrointestinal Events in a Double-Blind Trial of the Cyclo-Oxygenase-2 Selective Inhibitor Etoricoxib and the Traditional Nonsteroidal Anti-Inflammatory Drug Diclofenac

Anti-inflammatoryAnti-inflammatory AgentsPharmacological StudyGastrointestinal PharmacologyPharmacologyGastroenterologyDouble-blind TrialLower Gastrointestinal EventsPharmacotherapyMedicine